|
Volumn 254, Issue 2, 2011, Pages 385-386
|
The challenges of improving survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER CHEMOTHERAPY;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
HUMAN;
LETTER;
LIVER DISEASE;
LUNG DISEASE;
LYMPH NODE;
MORBIDITY;
PANCREAS CARCINOMA;
PANCREATIC DUCTAL ADENOCARCINOMA;
PANCREATICODUODENECTOMY;
PERITONEAL DISEASE;
POSTOPERATIVE CARE;
PREOPERATIVE RADIOTHERAPY;
PRIORITY JOURNAL;
RETROPERITONEAL DISEASE;
CARCINOMA, PANCREATIC DUCTAL;
DISEASE PROGRESSION;
HUMANS;
LYMPHATIC METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PANCREATIC NEOPLASMS;
PANCREATICODUODENECTOMY;
POSTOPERATIVE COMPLICATIONS;
PROGNOSIS;
SURVIVAL RATE;
|
EID: 79961081838
PISSN: 00034932
EISSN: 15281140
Source Type: Journal
DOI: 10.1097/SLA.0b013e31822682b7 Document Type: Letter |
Times cited : (6)
|
References (8)
|